<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="editorial">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">7NGx485SX4HgXpjmmDMjYpw</article-id>
      <article-id pub-id-type="other">00009</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2000000700009</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(00)07500109</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2000000700009</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Ponto de Vista</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Iatrogenia em cardiologia</article-title>
        <trans-title-group xml:lang="en">
          <trans-title>Iatrogeny in cardiology</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Pereira</surname>
            <given-names>Afonso Celso</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Franken</surname>
            <given-names>Roberto Alexandre</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sprovieri</surname>
            <given-names>Sandra Regina Schwarzwalder</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Golin</surname>
            <given-names>Valdir</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Santa Casa de Miseric&#243;rdia de S&#227;o Paulo</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>07</month>
        <year>2000</year>
      </pub-date>
      <volume>75</volume>
      <issue>1</issue>
      <fpage>75</fpage>
      <lpage>78</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>01</month>
          <year>2000</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>03</month>
          <year>2000</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>O termo iatrogenia vem do grego e refere-se a qualquer altera&#231;&#227;o patol&#243;gica provocada no paciente pela m&#225; pr&#225;tica m&#233;dica. Infelizmente, o risco de sua ocorr&#234;ncia convive constantemente no manuseio das doen&#231;as card&#237;acas. Podem ser considerados dois tipos de iatrogenia: iatrogenia de a&#231;&#227;o, ou decorrente da a&#231;&#227;o m&#233;dica, e iatrogenia de omiss&#227;o, relacionada &#224; falta de a&#231;&#227;o do m&#233;dico. As iatrogenias ocorrem em todas as fases do ato m&#233;dico, desde a rela&#231;&#227;o com o paciente, passando pelo diagn&#243;stico, tratamento, at&#233; a preven&#231;&#227;o das doen&#231;as. O presente artigo comenta as iatrogenias no campo das doen&#231;as card&#237;acas e cita alguns exemplos de como ocorrem.</p>
      </abstract>
      <trans-abstract xml:lang="en">
        <p>The word iatrogeny derives from the Greek and concerns any disorder caused to the patient by inaproppriate medical practice. Unfortunately, the rise of an iatrogenic disease is related to the daily handline of cardiac disease. There are two types of iatrogeny: that caused by a medical action and omission iatrogeny, caused by the lack of a medical action. Iatrogeny occurs in all steps of medical practice starting with the patient-doctor relationship including diagnosis treatment and finally prevention of diseases. This article makes a brief commentary about iatrogenic heart disease and mentions some examples of it.</p>
      </trans-abstract>
      <pub-date publication-format="electronic" date-type="pub">
        <day>08</day>
        <month>01</month>
        <year>2002</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>Ponto de Vista</bold>
    </p>
    <p>
      <bold>Iatrogenia em Cardiologia </bold>
    </p>
    <p>Afonso Celso Pereira, Roberto Alexandre Franken, Sandra Regina Schwarzwalder Sprovieri, Valdir Golin </p>
    <p>
      <bold>S&#227;o Paulo, SP </bold>
    </p>
    <p>O termo iatrogenia vem do grego e refere-se a qualquer altera&#231;&#227;o patol&#243;gica provocada no paciente pela m&#225; pr&#225;tica m&#233;dica. Infelizmente, o risco de sua ocorr&#234;ncia convive constantemente no manuseio das doen&#231;as card&#237;acas. Podem ser considerados dois tipos de iatrogenia: iatrogenia de a&#231;&#227;o, ou decorrente da a&#231;&#227;o m&#233;dica, e iatrogenia de omiss&#227;o, relacionada &#224; falta de a&#231;&#227;o do m&#233;dico. As iatrogenias ocorrem em todas as fases do ato m&#233;dico, desde a rela&#231;&#227;o com o paciente, passando pelo diagn&#243;stico, tratamento, at&#233; a preven&#231;&#227;o das doen&#231;as. O presente artigo comenta as iatrogenias no campo das doen&#231;as card&#237;acas e cita alguns exemplos de como ocorrem. </p>
    <p>
      <bold>Iatrogeny in Cardiology </bold>
    </p>
    <p>The word iatrogeny derives from the Greek and concerns any disorder caused to the patient by inaproppriate medical practice. Unfortunately, the rise of an iatrogenic disease is related to the daily handline of cardiac disease. There are two types of iatrogeny: that caused by a medical action and omission iatrogeny, caused by the lack of a medical action. Iatrogeny occurs in all steps of medical practice starting with the patient-doctor relationship including diagnosis treatment and finally prevention of diseases. This article makes a brief commentary about iatrogenic heart disease and mentions some examples of it. </p>
    <p>"Aqui jaz um homem rico, nessa rica sepultura, </p>
    <p> escapava da mol&#233;stia, se n&#227;o morresse da cura". </p>
    <p> Bocage </p>
    <p>O potencial risco iatrog&#234;nico convive constantemente com o diagn&#243;stico e tratamento das doen&#231;as card&#237;acas, sejam de abordagem cl&#237;nica ou cir&#250;rgica. Considerando que os progressos em cardiologia s&#227;o constantes e din&#226;micos, podemos admitir que determinados m&#233;todos diagn&#243;sticos ou terap&#234;uticos, que apresentam hoje indica&#231;&#245;es na abordagem do doente, poder&#227;o no futuro ser&#227;o alvos de complica&#231;&#245;es ainda ignoradas, cuja pr&#225;tica que at&#233; ent&#227;o n&#227;o era, passar&#225; a ser considerada iatrog&#234;nica. </p>
    <p>O termo iatrogenia deriva do grego (iatros = m&#233;dico / gignesthai = nascer, que deriva da palavra genesis = produzir) e significa qualquer altera&#231;&#227;o patol&#243;gica provocada no paciente pela m&#225; pr&#225;tica m&#233;dica <sup>1,2</sup>. </p>
    <p>O termo doen&#231;a card&#237;aca iatrog&#234;nica &#233; usualmente definido como doen&#231;a do cora&#231;&#227;o induzida pelo m&#233;dico <sup>1,2</sup>. </p>
    <p>As iatrogenias em cardiologia ficam bem definidas quando se observam les&#245;es card&#237;acas, modifica&#231;&#245;es funcionais (el&#233;tricas e/ou mec&#226;nicas), altera&#231;&#245;es em outros &#243;rg&#227;os ou modifica&#231;&#245;es comportamentais, secund&#225;rias &#224; indevida orienta&#231;&#227;o nos procedimentos diagn&#243;sticos terap&#234;uticos ou profil&#225;ticos das doen&#231;as cardiovasculares <sup>3</sup>. O risco de iatrogenia cresce &#224; medida que aumentam o n&#250;mero de a&#231;&#245;es terap&#234;uticas e diagn&#243;sticas. </p>
    <p>Podemos considerar dois tipos de iatrogenias: 1) iatrogenia de a&#231;&#227;o: aquela que ocorre pela a&#231;&#227;o m&#233;dica, desde a rela&#231;&#227;o com o paciente, passando pelo diagn&#243;stico, terap&#234;utica, at&#233; a preven&#231;&#227;o. Caracteriza imprud&#234;ncia ou imper&#237;cia m&#233;dica; 2) iatrogenia de omiss&#227;o: aquela que ocorre pela falta de a&#231;&#227;o do m&#233;dico, quer no diagn&#243;stico, quer no tratamento, portanto, ato negligente. </p>
    <p>Iatrogenias podem amea&#231;ar a qualidade de vida do paciente, &#224; medida que seq&#252;elas se mantenham definitivamente. Com o progressivo maior n&#250;mero de op&#231;&#245;es terap&#234;uticas e m&#233;todos diagn&#243;sticos, eleva-se o risco de iatrogenia. Cabe aqui considerarmos que o compromisso do m&#233;dico &#233; com o bom atendimento ao doente, do ponto de vista t&#233;cnico e humano, e n&#227;o s&#243; com o sucesso terap&#234;utico ou diagn&#243;stico, mas sim conseq&#252;&#234;ncia da premissa inicial. A obriga&#231;&#227;o m&#233;dica para com seu paciente n&#227;o &#233; de resultados, mas sim de dilig&#234;ncia. </p>
    <p>Discuss&#227;o </p>
    <p><bold>Iatrogenia de a&#231;&#227;o</bold> - A iatrogenia de a&#231;&#227;o m&#233;dica ocorre em sua rela&#231;&#227;o com o paciente, nos riscos gerados pelos f&#225;rmacos, procedimentos, cirurgias na m&#225; interpreta&#231;&#227;o de informa&#231;&#245;es cl&#237;nicas e dos exames subsidi&#225;rios. </p>
    <p>Na atualidade, com ampla tecnologia e op&#231;&#245;es nos m&#233;todos diagn&#243;sticos e terap&#234;uticos, existe um aumento nas chances de infort&#250;nios <sup>4</sup>. Segundo Melmon <sup>5</sup>, o n&#250;mero de acidentes anuais com procedimentos m&#233;dicos nos Estados Unidos &#233; pr&#243;ximo ao n&#250;mero de acidentes automobil&#237;sticos, atingindo mortalidade de 180.000 pacientes ano. Obviamente, o uso de alguns procedimentos est&#225; associado a complica&#231;&#245;es mesmo quando usados de maneira adequada e por profissionais experientes. Portanto, torna-se importante separar as complica&#231;&#245;es, que ocorrem a despeito de uso adequado e por profissional capacitado, daquelas por orienta&#231;&#227;o indevida e despreparo t&#233;cnico. Assim, iatrogenias devem ser diferenciadas de situa&#231;&#245;es, como riscos inerentes a determinados procedimentos e/ou efeitos colaterais de medicamentos. Esta defini&#231;&#227;o n&#227;o &#233; un&#226;nime. De acordo com Rubins e Moskowitz <sup>6</sup>, complica&#231;&#227;o iatrog&#234;nica &#233; definida como uma ocorr&#234;ncia perniciosa, intencional resultante de procedimento m&#233;dico, diagn&#243;stico, terap&#234;utico, profil&#225;tico ou les&#227;o acidental ocorrida no hospital. No entender de Serra <sup>7</sup>, deve-se excluir da defini&#231;&#227;o de doen&#231;a iatrog&#234;nica, a imper&#237;cia e/ou a ignor&#226;ncia m&#233;dica e "s&#243; considerar o que &#233; realizado impecavelmente". Ao contr&#225;rio, entendemos por iatrogenia o fato gerado por m&#225; orienta&#231;&#227;o ou inabilidade m&#233;dica e n&#227;o risco inerente dos procedimentos e suas conseq&#252;&#234;ncias. </p>
    <p>O risco de iatrogenia &#233; o dobro em pacientes acima de 65 anos de idade, comparado com pacientes entre 16 e 44 anos. &#201; tamb&#233;m o dobro em servi&#231;os de cl&#237;nica m&#233;dica em rela&#231;&#227;o ao de cl&#237;nicas cir&#250;rgicas <sup>8</sup>. </p>
    <p>a) <bold>A rela&#231;&#227;o do m&#233;dico com seu paciente</bold> pode levar a seq&#252;elas comportamentais, que geralmente n&#227;o s&#227;o consideradas iatrogenias. Basta citar um exemplo dos mais habituais: crian&#231;a de sete anos de idade, levada ao m&#233;dico pediatra cardiologista, que n&#227;o se deixa auscultar, pois chora sem parar. No intuito de conseguir terminar o exame, o m&#233;dico amea&#231;a a crian&#231;a com uma inje&#231;&#227;o se n&#227;o silenciar. As seq&#252;elas comportamentais para a vida dessa crian&#231;a poder&#227;o ser marcantes. </p>
    <p>b) Todos os medicamentos podem produzir efeitos indesej&#225;veis. O m&#233;dico deve sempre discutir com seu paciente a probabilidade desses efeitos antes de prescrev&#234;-los, assim como avaliar a rela&#231;&#227;o risco/benef&#237;cio do seu uso. </p>
    <p><bold>Os</bold><bold>efeitos indesejados dos medicamentos</bold> podem ser considerados como iatrogenia somente se o m&#233;dico n&#227;o tiver conhecimento desta possibilidade na avalia&#231;&#227;o do risco sendo que outra droga menos t&#243;xica poderia ter sido usada. Tamb&#233;m ser&#225; considerado iatrogenia se, al&#233;m da falha em se reconhecer os efeitos colaterais, o profissional insistir na terap&#234;utica j&#225; demonstrada como ineficiente. No nosso entender, o efeito colateral de um medicamento bem indicado, n&#227;o deve ser considerado iatrogenia. </p>
    <p>Erros de prescri&#231;&#227;o s&#227;o respons&#225;veis por at&#233; 56% dos casos de efeitos adversos previs&#237;veis de medicamentos. Os erros em dosagens na prescri&#231;&#227;o s&#227;o feitos primariamente pelos m&#233;dicos por falta de conhecimento adequado dos f&#225;rmacos ou do doente a quem vai ser prescrito o produto <sup>9</sup>. Em cardiologia, todos os medicamentos usados para o tratamento de arritmias card&#237;acas, podem desencade&#225;-las. O efeito arritmog&#234;nico de drogas antiarr&#237;tmicas, especialmente do grupo I, &#224;s vezes &#233; fatal <sup>10-12</sup>. Muitas vezes condutas consideradas corretas passaram a ser julgadas iatrog&#234;nicas. Medicamentos antiarr&#237;tmicos eram usados com base no conceito de que a elimina&#231;&#227;o das extra-s&#237;stoles ventriculares diminuiriam a probabilidade de morte arr&#237;tmica. Demonstrou-se, posteriormente, que medicamentos do grupo I, especialmente em ventr&#237;culos doentes, aumentavam a mortalidade <sup>13</sup>. De acordo com Bedell e cols. <sup>14</sup>, 14% das paradas card&#237;acas s&#227;o iatrog&#234;nicas, geralmente associadas ao mal uso de medicamentos, os mais freq&#252;entemente envolvidos, digital e antiarr&#237;tmicos do grupo I. </p>
    <p>F&#225;rmacos usados para o controle de hipertens&#227;o arterial sist&#234;mica podem produzir hipotens&#227;o postural, s&#237;ncope e bradiarritmias <sup>15,16</sup>. Nitratos prescritos para angina de peito podem causar hipotens&#227;o postural e s&#237;ncope <sup>17,18</sup>. Betabloqueadores usados para angina ou hipertens&#227;o podem precipitar s&#237;ndrome do n&#243; sinusal, bloqueio atrioventricular e insufici&#234;ncia card&#237;aca <sup>16,17</sup>. Bloqueadores de canais de c&#225;lcio podem provocar v&#225;rios efeitos card&#237;acos indesej&#225;veis, como o verapamil que diminui a contratilidade mioc&#225;rdica e pode precipitar insufici&#234;ncia card&#237;aca, s&#237;ndrome do n&#243; sinusal e bloqueio atrioventricular. Nifedipina, numa pequena porcentagem de pacientes agrava a angina de peito. Diltiazem diminui a contratilidade card&#237;aca e pode levar a bradiarritmias <sup>17,19</sup>. Diur&#233;ticos, como a furosemida, hidroclorotiazida, utilizados no tratamento da insufici&#234;ncia card&#237;aca, s&#227;o capazes de levar a hipopotassemia, hipomagnesemia, precipitando arritmias card&#237;acas <sup>20</sup>. O &#225;cido acetilsalic&#237;lico, utilizado para prevenir ataques isqu&#234;micos cerebrais ou trombose coronariana, pode produzir sangramento gastrointestinal <sup>21</sup>. Agentes trombol&#237;ticos, como estreptoquinase ou ativador do plasminog&#234;nio tecidual recombinante podem provocar hemorragia cerebral <sup>22</sup>. Digit&#225;licos para o tratamento da insufici&#234;ncia card&#237;aca podem levar a arritmias ventriculares e bloqueio atrioventricular <sup>23</sup>. Tric&#237;clicos podem produzir bloqueios de ramos do feixe de His <sup>24</sup>. Doxorrubicina e daunorrubicina, quimioter&#225;picos usados no tratamento de doen&#231;a neopl&#225;sica podem levar a cardiomiopatia <sup>25</sup>. </p>
    <p>Estes acidentes medicamentosos s&#227;o exemplos de efeitos colaterais de drogas, que se adequadamente indicadas, n&#227;o caracterizam iatrogenia, por&#233;m, se mal indicadas, como por exemplo, digit&#225;licos para pacientes com disfun&#231;&#227;o diast&#243;lica, caracterizam iatrogenia. O mesmo acontece no caso de aparecimento de efeitos colaterais n&#227;o reconhecidos pelo m&#233;dico ou, o que &#233; pior, passar a tratar o novo sintoma com outros f&#225;rmacos, aumentando o risco. &#201; o que ocorre na intoxica&#231;&#227;o digit&#225;lica com arritmia em que ao inv&#233;s de se suspender o digital, associa-se antiarr&#237;tmico. </p>
    <p>De acordo com a Organiza&#231;&#227;o Mundial de Sa&#250;de, efeito adverso de um medicamento &#233; o seu efeito danoso, que ocorre em doses habituais, quando indicado de forma apropriada na profilaxia, diagn&#243;stico ou terap&#234;utica. Portanto, no nosso entender, n&#227;o se incluem nas iatrogenias. </p>
    <p>No idoso, como observamos, a iatrogenia &#233; mais freq&#252;ente e geralmente resultado de uma situa&#231;&#227;o cl&#237;nica ca&#243;tica, por&#233;m, mesmo assim, de acordo com Lefevre e cols. <sup>26</sup> pass&#237;vel em geral, de previs&#227;o atrav&#233;s de conhecimento t&#233;cnico mais acurado, aten&#231;&#227;o no procedimento e estudo funcional adequado do paciente <sup>27</sup>. Paciente idoso com d&#233;ficit de fun&#231;&#227;o renal n&#227;o recebem em geral sua dose de digital adequada. Iatrogenia &#233; hoje mais comum que em eras passadas. Informa&#231;&#245;es em abund&#226;ncia que, por um lado dificultam a atualiza&#231;&#227;o adequada do profissional, por outro levam ao que Meyer chamou de <italic>therapeutic hyperenthusiasm</italic>, estimulando o uso de medicamentos mal indicados ou em doses inadequadas <sup>28</sup>. </p>
    <p><bold>c) </bold>Interpreta&#231;&#227;o equivocada de sintomas talvez seja o problema mais freq&#252;ente na avalia&#231;&#227;o de hist&#243;ria de dor no peito, relacionada ou n&#227;o com doen&#231;a coronariana. De fato, este &#233; o principal exemplo de <bold>m&#225; interpreta&#231;&#227;o de informa&#231;&#245;es cl&#237;nicas</bold>. At&#233; mesmo cardiologistas experientes admitem que a taxa de erro &#233; consider&#225;vel <sup>33</sup>. Dor precordial, em pronto socorro, &#233; uma das maiores causas de processos m&#233;dicos nos Estados Unidos. Deve-se evitar dispensar do pronto socorro paciente com queixa compat&#237;vel com doen&#231;a coronariana, de acordo com as normatiza&#231;&#227;o das sociedades m&#233;dicas credenciadas. </p>
    <p>A m&#225; interpreta&#231;&#227;o de dados dos exames f&#237;sico ou subsidi&#225;rios &#233; tamb&#233;m causa habitual de iatrogenia. </p>
    <p>Ausculta de sopro sist&#243;lico em foco pulmonar ou mitral, habitual na gravidez, se mal interpretada, pode levar a iatrogenia com modifica&#231;&#245;es comportamentais da m&#227;e durante a gesta&#231;&#227;o, e por toda a vida. </p>
    <p>d) O eletrocardiograma continua sendo um dos principais fatores associados a iatrogenias em cardiologia, <bold>devido a m&#225; interpreta&#231;&#227;o de exames subsedi&#225;rios</bold>. O m&#233;dico inexperiente pode n&#227;o valorizar doen&#231;a coronariana grave em paciente que apresenta eletrocardiograma normal, ou diagnosticar angina inst&#225;vel ou infarto agudo do mioc&#225;rdio em indiv&#237;duo apresentando bloqueio completo de ramo esquerdo, s&#237;ndrome de Wolf-Parkinson-White ou repolariza&#231;&#227;o precoce <sup>29</sup>. Outro fato observado, com freq&#252;&#234;ncia, &#233; o n&#227;o reconhecimento no eletrocardiograma de situa&#231;&#245;es de risco para parada card&#237;aca <sup>30,31</sup>, ou sinais frustros de insufici&#234;ncia coronariana em pacientes com hist&#243;ria compat&#237;vel. </p>
    <p>Anormalidade de reperfus&#227;o &#226;ntero-septal evidenciada no teste de esfor&#231;o com t&#225;lio pode ocorrer por bloqueio de ramo esquerdo e n&#227;o estar indicando aterosclerose coronariana <sup>32</sup>. </p>
    <p>A identifica&#231;&#227;o pelo ecodopplercardiograma, de pequena quantidade de regurgita&#231;&#227;o valvar, pode levar o m&#233;dico pouco experiente, ao diagn&#243;stico de insufici&#234;ncia mitral, a&#243;rtica, pulmonar ou tric&#250;spide, na realidade inexistentes. </p>
    <p>Devemos ainda, considerar os casos de iatrogenia em complica&#231;&#245;es de exames invasivos mal indicados. </p>
    <p><bold>A Iatrogenia de omiss&#227;o</bold> - &#233; devida a falta de a&#231;&#227;o do m&#233;dico. A omiss&#227;o ocorre, geralmente, pela m&#225; avalia&#231;&#227;o do risco da a&#231;&#227;o. Eventualmente, o m&#233;dico n&#227;o age pelo temor dos efeitos colaterais dos procedimentos, at&#233; mesmo pelo risco de morte. Nesta situa&#231;&#227;o o que se faz &#233; deixar a doen&#231;a evoluir naturalmente sob tratamento mais conservador e supostamente de menor risco. Exemplificamos com as seguintes situa&#231;&#245;es: 1) paciente com diagn&#243;stico de endocardite infecciosa, recebendo antibioticoterapia apropriada, evoluindo com piora cl&#237;nica. &#201; evidenciado abscesso de anel e envolvimento do seio de Valsalva. No entanto, &#233; mantida a terap&#234;utica inicial e n&#227;o se indica cirurgia, vindo o paciente a falecer; 2) paciente de 76 anos, com quadro de infarto agudo do mioc&#225;rdio. O m&#233;dico que o assiste no servi&#231;o de emerg&#234;ncia deixa de empregar o trombol&#237;tico que disp&#245;e, por achar equivocadamente, a idade do paciente fator de impedimento, primeiro pelo o risco cir&#250;rgico, segundo, pelo risco de sangramento em idoso, gerando assim omiss&#227;o por falta de conhecimento das evid&#234;ncias de benef&#237;cios dos procedimento contra o risco da indica&#231;&#227;o da a&#231;&#227;o. </p>
    <p>Iatrogenia de a&#231;&#227;o ou omiss&#227;o tem sido descrita como dependentes do m&#233;dico, por&#233;m independentes da sua habilidade. Bates e cols. <sup>34</sup> relacionam a fadiga, o estresse e, acima de tudo, a distra&#231;&#227;o, durante o ato m&#233;dico (especificamente, a prescri&#231;&#227;o) e, geralmente devido interrup&#231;&#227;o circust&#226;ncial do racioc&#237;nio, como causas de iatrogrenia. A proposta &#233; que a exemplo do que se faz em aeron&#225;utica, seja tamb&#233;m a prescri&#231;&#227;o, um ato informatizado, que permita captar os erros antes da sua execu&#231;&#227;o. Finalmente, &#233; necess&#225;rio que se fa&#231;a an&#225;lise sistem&#225;tica do servi&#231;o m&#233;dico, com objetivo de encontrar erros repetitivos (qualidade de atendimento) e preven&#237;-los. Al&#233;m disso, com o objetivo de prevenir iatrogenias, deve-se estimular educa&#231;&#227;o continuada e divulga&#231;&#227;o dos guias de atendimento nos diferentes aspectos da atua&#231;&#227;o m&#233;dica. </p>
    <p>Conclus&#227;o </p>
    <p>O m&#233;dico deve ter como objetivo na sua rotina de trabalho, al&#233;m do adequado atendimento ao seu paciente, a preven&#231;&#227;o das doen&#231;a iatrog&#234;nicas. Cabe estar alerta quanto aos efeitos indesej&#225;veis dos medicamentos, &#224;s complica&#231;&#245;es dos m&#233;todos diagn&#243;sticos e dos procedimentos terap&#234;uticos e profil&#225;ticos e sua rela&#231;&#227;o com o paciente. Atentar para a hist&#243;ria cl&#237;nica e aos sinais obtidos pelo exame f&#237;sico executado com t&#233;cnica adequada. Interpretar corretamente os exames subsidi&#225;rios &#224; luz dos dados cl&#237;nicos, avaliar funcionalmente o paciente e, sempre que poss&#237;vel, seguir as normas das sociedades m&#233;dicas credenciadas e, sobretudo, dedicar-se integralmente ao ato m&#233;dico, impedindo desvios de aten&#231;&#227;o. Por fim, considerar a omiss&#227;o t&#227;o danosa quanto a a&#231;&#227;o mal indicada. </p>
    <p>Agradecimentos </p>
    <p>Ao Prof. Dr. Vitor Pereira pela revis&#227;o e sugest&#245;es no texto. </p>
    <p>Santa Casa de Miseric&#243;rdia de S&#227;o Paulo </p>
    <p> Correspond&#234;ncia: Afonso Celso Pereira &#190; Rua Volunt&#225;rios da P&#225;tria, 4040 Ap. 174 CEP 02402-500 - S&#227;o Paulo, SP </p>
    <p> Recebido para publica&#231;&#227;o em 5/1/00 </p>
    <p> Aceito em 23/3/00 </p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Auerback A, Gliebe PA. Iatrogenic heart disease: common cardiac neurosis<italic>. </italic>JAMA 1945; 129: 338-41. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Iatrogenic heart disease: common cardiac neurosis</article-title>
          <source>JAMA</source>
          <date>
            <year>1945</year>
          </date>
          <fpage>338</fpage>
          <lpage>41</lpage>
          <volume>129</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Auerback</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gliebe</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Sevin BH. Mitral valve prolapse, panic states, and anxiety. Psychiatry Clin North Am 1987; 10: 141-150. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mitral valve prolapse, panic states, and anxiety</article-title>
          <source>Psychiatry Clin North Am</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>141</fpage>
          <lpage>150</lpage>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sevin</surname>
              <given-names>BH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Wheeler EO, Williamson CR, Cohen ME. Heart scare, heart surveys, and iatrogenic heart disease: emotional and symptomatological effects of suggesting to one hundred sixty-two adults that they might have heart disease. JAMA 1958; 167: 1096-102. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Heart scare, heart surveys, and iatrogenic heart disease: emotional and symptomatological effects of suggesting to one hundred sixty-two adults that they might have heart disease</article-title>
          <source>JAMA</source>
          <date>
            <year>1958</year>
          </date>
          <fpage>1096</fpage>
          <lpage>102</lpage>
          <volume>167</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wheeler</surname>
              <given-names>EO</given-names>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Weinberg HB. Iatrogenic heart disease. Ann Intern Med 1953; 38: 9-22. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Iatrogenic heart disease</article-title>
          <source>Ann Intern Med</source>
          <date>
            <year>1953</year>
          </date>
          <fpage>9</fpage>
          <lpage>22</lpage>
          <volume>38</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Weinberg</surname>
              <given-names>HB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Melmon KL, Preventable drug reaction causes and cures semin. Med Beth Israel Hosp 1971; 284: 1361-7. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Preventable drug reaction causes and cures semin</article-title>
          <source>Med Beth Israel Hosp</source>
          <date>
            <year>1971</year>
          </date>
          <fpage>1361</fpage>
          <lpage>7</lpage>
          <volume>284</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Melmon</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Rubin HA, Moskowitz MA. Complications of care in a medical intensive care unit. J Gen Intern Med 1990; 5: 104-09. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Complications of care in a medical intensive care unit</article-title>
          <source>J Gen Intern Med</source>
          <date>
            <year>1990</year>
          </date>
          <fpage>104</fpage>
          <lpage>09</lpage>
          <volume>5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rubin</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Moskowitz</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Serra AV. Doen&#231;a iatrog&#281;nica. Coimbra Med 1985; 4-5: 161-9. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Doen&#231;a iatrog&#234;nica</article-title>
          <source>Coimbra Med</source>
          <date>
            <year>1985</year>
          </date>
          <fpage>161</fpage>
          <lpage>9</lpage>
          <volume>4-5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Serra</surname>
              <given-names>AV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377-84. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The nature of adverse events in hospitalized patients</article-title>
          <source>Results of the Harvard Medical Practice Study II. N Engl J Med</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>377</fpage>
          <lpage>84</lpage>
          <volume>324</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Leape</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Laird</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9. Reducting errors in health care. Research in aviation, September 1998. Agency for Health Care Policy abd Research. Rockville, MD. <ext-link ext-link-type="uri" xlink:href="http://wwwahcpr.gov/research/erros.htm">http://wwwahcpr.gov/research/erros.htm</ext-link>.</mixed-citation>
        <element-citation publication-type="book">
          <source>Reducting errors in health care: Research in aviation, September 1998. Agency for Health Care Policy abd Research</source>
          <comment>&lt;A HREF="http://wwwahcpr.gov/research/erros.htm"&gt;http://wwwahcpr.gov/research/erros.htm&lt;/A&gt;</comment>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Singh BN, Collet JT, Chew CY. New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis 1980; 93: 875-85. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>New perspectives in the pharmacologic therapy of cardiac arrhythmias</article-title>
          <source>Prog Cardiovasc Dis</source>
          <date>
            <year>1980</year>
          </date>
          <fpage>875</fpage>
          <lpage>85</lpage>
          <volume>93</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>BN</given-names>
            </name>
            <name>
              <surname>Collet</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Chew</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Wooley RL. Antiarrhythimic drugs. Annu Rev Pharmacol Toxicol 1991; 31: 427-33. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Antiarrhythimic drugs</article-title>
          <source>Annu Rev Pharmacol Toxicol</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>427</fpage>
          <lpage>33</lpage>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wooley</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Arnsdorf MF. Electrophysiologic properties of antidysrhythmic drugs as a rational basis for therapy. Med Clin North Am 1976; 60: 213-32. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Electrophysiologic properties of antidysrhythmic drugs as a rational basis for therapy</article-title>
          <source>Med Clin North Am</source>
          <date>
            <year>1976</year>
          </date>
          <fpage>213</fpage>
          <lpage>32</lpage>
          <volume>60</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Arnsdorf</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Echt DS, Liebson PR, Mitchell B, et al. Mortality and morbidity in patients receiving ecainide flecainide or placebo the cardiac arrhythmia supression trial. N Engl J Med 1991; 324: 781-8. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mortality and morbidity in patients receiving ecainide flecainide or placebo the cardiac arrhythmia supression trial</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>781</fpage>
          <lpage>8</lpage>
          <volume>324</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Echt</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Liebson</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Bedell SE, Deitz DC, Leeman D, et al. Incidence and characteristics of preventable iatrogenic cardiac arrest. JAMA 1991; 265: 2815-20. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Incidence and characteristics of preventable iatrogenic cardiac arrest</article-title>
          <source>JAMA</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>2815</fpage>
          <lpage>20</lpage>
          <volume>265</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bedell</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Deitz</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Leeman</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. The Fifth Report of the Joint National Committee on Detection, Education, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-83. </mixed-citation>
        <element-citation publication-type="journal">
          <source>Arch Intern Med</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>154</fpage>
          <lpage>83</lpage>
          <volume>153</volume>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA 1997; 277: 739-45. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis</article-title>
          <source>JAMA</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>739</fpage>
          <lpage>45</lpage>
          <volume>277</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Psaty</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Siscovick</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Smith ER, Smiseth AO, Kingma I, et al. Mechanism of action of nitrates. Role of changes in venous capacitance and in the left ventricular diastolic pressure volume relation. Am J Med 1984; 76: 14-21. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mechanism of action of nitrates</article-title>
          <source>Role of changes in venous capacitance and in the left ventricular diastolic pressure volume relation. Am J Med</source>
          <date>
            <year>1984</year>
          </date>
          <fpage>14</fpage>
          <lpage>21</lpage>
          <volume>76</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Smiseth</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Kingma</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Murad F. Drugs used for the treatment of angina: organic nitrates, calcium-channel blockers , and B- adrenergic antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8<sup>th</sup> ed. New York, NY: Macmillan Publishing Co. Inc., 1979: 69-76. </mixed-citation>
        <element-citation publication-type="book">
          <source>Goodman and Gilman's The Pharmacological Basis of Therapeutics</source>
          <date>
            <year>1979</year>
          </date>
          <fpage>69</fpage>
          <lpage>76</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Murad</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gilman</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Rall</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Nies</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Furberg CD, , et al. Nifedipine: Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-31. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nifedipine: Dose-related increase in mortality in patients with coronary heart disease</article-title>
          <source>Circulation</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>1326</fpage>
          <lpage>31</lpage>
          <volume>92</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Furberg</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Cogan MG. Fluid and Electrolytes. Physiology and Pathophysiology - 3<sup>th</sup> ed. Stamford,Connecticut: Appleton &amp; Lange 1991; 2: 20. </mixed-citation>
        <element-citation publication-type="book">
          <source>Fluid and Electrolytes. Physiology and Pathophysiology</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>2: 20</fpage>
          <person-group person-group-type="author">
            <name>
              <surname>Cogan</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Thompson PL, Aylward PE, Federman J, et al. A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 h after recombinant tissue-type plasminogen activator for acute myocardial infarction.Circulation 1991; 83: 1534-42. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 h after recombinant tissue-type plasminogen activator for acute myocardial infarction</article-title>
          <source>Circulation</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>1534</fpage>
          <lpage>42</lpage>
          <volume>83</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Thompson</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Aylward</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Federman</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Cairns JS, , et al. Coronary thrombolysis. Chest 1995; 108: 401s. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary thrombolysis</article-title>
          <source>Chest</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>401s</fpage>
          <volume>108</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cairns</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. The Digitalis Investigation Group. The effects of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The effects of digoxin on mortality and morbidity in patients with heart failure</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>525</fpage>
          <lpage>33</lpage>
          <volume>336</volume>
          <person-group person-group-type="author">
            <name>
              <surname>The</surname>
              <given-names>Digitalis Investigation Group</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Newton EH, Shih RD, Hoffman RS. Cyclic antidepressant overdose: A review of current management strategies. Am J Emerg Med 1994; 12: 376-82. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cyclic antidepressant overdose: A review of current management strategies</article-title>
          <source>Am J Emerg Med</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>376</fpage>
          <lpage>82</lpage>
          <volume>12</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Newton</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Shih</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Dorr RT, Von Hoff DD. Cancer chemotherapy Handbook. 5<sup>th</sup> ed. (editors). Stamford, Connecticut: Appleton &amp; Lange, 1994; 10: 21. </mixed-citation>
        <element-citation publication-type="book">
          <source>Cancer chemotherapy Handbook</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>21</fpage>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dorr</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Von Hoff</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Lefevre F, Feruglas J, Pootts S, et al. Iatrogenic complications in high risk elderly patients. Arch Int Med 1992; 152: 2074-80. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Iatrogenic complications in high risk elderly patients</article-title>
          <source>Arch Int Med</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>2074</fpage>
          <lpage>80</lpage>
          <volume>152</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lefevre</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Feruglas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pootts</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Becker PM, McVey LJ, Satz CC, et al. Hospital acquired complication in randomized controlled clinical trial of a geriatric consultation team. JAMA 1987; 257: 2313-17. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hospital acquired complication in randomized controlled clinical trial of a geriatric consultation team</article-title>
          <source>JAMA</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>2313</fpage>
          <lpage>17</lpage>
          <volume>257</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Becker</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>McVey</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Satz</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Myer JD. Preventing iatrogenic complications. N Engl J Med 1981; 304: 664-5. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Preventing iatrogenic complications</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1981</year>
          </date>
          <fpage>664</fpage>
          <lpage>5</lpage>
          <volume>304</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Myer</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Taggart P, Carruthers M, Joseph S, and Somerville W. Electrocardiografic changes resembling myocardial ischaemia in asymptomatic men with normal coronary arteriograms. Br Heart J 1979; 42: 214-29. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Electrocardiografic changes resembling myocardial ischaemia in asymptomatic men with normal coronary arteriograms</article-title>
          <source>Br Heart J</source>
          <date>
            <year>1979</year>
          </date>
          <fpage>214</fpage>
          <lpage>29</lpage>
          <volume>42</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Taggart</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Carruthers</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Joseph</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Somerville</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Selzer A, Wray W. Quinidine syncope, aproxismal ventricular fibrillation occuring durng treatment of chronic atrial arrhythmias. Circulation 1964; 30: 17-26. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quinidine syncope, aproxismal ventricular fibrillation occuring durng treatment of chronic atrial arrhythmias</article-title>
          <source>Circulation</source>
          <date>
            <year>1964</year>
          </date>
          <fpage>17</fpage>
          <lpage>26</lpage>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Selzer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wray</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Keven A, Tzivoni D, Gavish D, et al. Warning signs and therapy of torsade de pointe. Circulation 1981; 64: 1167-74. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Warning signs and therapy of torsade de pointe</article-title>
          <source>Circulation</source>
          <date>
            <year>1981</year>
          </date>
          <fpage>1167</fpage>
          <lpage>74</lpage>
          <volume>64</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Keven</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tzivoni</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gavish</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Zaret BL, Wackers FJ. Nuclear cardiology. N Engl J Med 1993; 329: 775-85. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nuclear cardiology</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>775</fpage>
          <lpage>85</lpage>
          <volume>329</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Zaret</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Wackers</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Hart AD. Iatrogenics and cardiacs neurosis - Critique. Ann Intern Med 1953; 38: 9-22. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Iatrogenics and cardiacs neurosis - Critique</article-title>
          <source>Ann Intern Med</source>
          <date>
            <year>1953</year>
          </date>
          <fpage>9</fpage>
          <lpage>22</lpage>
          <volume>38</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hart</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: Implications for prevention. JAMA 1995; 274: 29-34. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Incidence of adverse drug events and potential adverse drug events: Implications for prevention</article-title>
          <source>JAMA</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>29</fpage>
          <lpage>34</lpage>
          <volume>274</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bates</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Cullen</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Laird</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
